GLOBAL BLOOD THERAPS Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GLOBAL BLOOD THERAPS, and when can generic versions of GLOBAL BLOOD THERAPS drugs launch?
GLOBAL BLOOD THERAPS has two approved drugs.
There are ten US patents protecting GLOBAL BLOOD THERAPS drugs.
There are two hundred and fifty-two patent family members on GLOBAL BLOOD THERAPS drugs in forty countries and eleven supplementary protection certificates in ten countries.
Summary for GLOBAL BLOOD THERAPS
International Patents: | 252 |
US Patents: | 10 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 2 |
Drugs and US Patents for GLOBAL BLOOD THERAPS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Global Blood Theraps | OXBRYTA | voxelotor | TABLET, FOR SUSPENSION;ORAL | 216157-001 | Dec 17, 2021 | RX | Yes | Yes | 10,806,733 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Global Blood Theraps | OXBRYTA | voxelotor | TABLET;ORAL | 213137-001 | Nov 25, 2019 | RX | Yes | Yes | 10,017,491 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Global Blood Theraps | OXBRYTA | voxelotor | TABLET;ORAL | 213137-001 | Nov 25, 2019 | RX | Yes | Yes | 11,020,382 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for GLOBAL BLOOD THERAPS Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Taiwan | 201512169 | ⤷ Try a Trial |
Australia | 2014237348 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2014150258 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for GLOBAL BLOOD THERAPS Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2797416 | 2290032-8 | Sweden | ⤷ Try a Trial | PRODUCT NAME: VOXELOTOR OR A TAUTOMER OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/21/1622 20220215 |
2797416 | LUC00276 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: VOXELOTOR OR A TAUTOMER OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; AUTHORISATION NUMBER AND DATE: EU/1/21/1622 20220215 |
2797416 | 301191 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: VOXELOTOR OF EEN TAUTOMEER OF FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/21/1622 20220215 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.